Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

274.82
Delayed Data
As of Mar 24
 -0.59 / -0.21%
Today’s Change
205.42
Today|||52-Week Range
307.33
+5.21%
Year-to-Date
Stock Market News for March 24, 2017
Mar 24 / Zacks.com - Paid Partner Content
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
Mar 20 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar 20 / TheStreet.com - Paid Partner Content
Five Stocks I Like on the Nasdaq Market
Mar 21 / GuruFocus News - Paid Partner Content
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Stock Market News for March 17, 2017
Mar 17 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
Mar 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close275.41
Today’s open277.08
Day’s range272.87 - 278.10
Volume1,368,217
Average volume (3 months)1,774,813
Market cap$59.3B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.58%
Earnings growth (next 5 years)+8.72%
Revenue growth (last year)+9.37%
P/E ratio17.6
Price/Sales6.09
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.02+0.03%
ILMNIllumina Inc+2.89+1.72%
BIVVBioverativ Inc-0.17-0.34%
KITEKite Pharma Inc+2.34+3.14%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$5.00
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs